Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 COP9 signalosome as a drug target for cancer and parasitic infections  





2 References  





3 Further reading  














COP9 signalosome






Čeština
Русский
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


COP9 (Constitutive photomorphogenesis 9) signalosome structure

COP9 (Constitutive photomorphogenesis 9) signalosome (CSN) is a protein complex with isopeptidase activity. It catalyses the hydrolysis of NEDD8 protein from the cullin subunit of Cullin-RING ubiquitin ligases (CRL). Therefore, it is responsible for CRL deneddylation – at the same time, it is able to bind denedyllated cullin-RING complex and retain them in deactivated form. COP9 signalosome thus serves as a sole deactivator of CRLs.[1] The complex was originally identified in plants,[2][3] and subsequently found in all eukaryotic organisms including human. [4] [5] Human COP9 signalosome (total size ~350 kDa) consists of 8 subunits - CSN1, CSN2, CSN3, CSN4, CSN5, CSN6, CSN7 (COPS7A, COPS7B), CSN8. All are essential for full function of the complex and mutation in some of them is lethal in mice.[1]


COP9 signalosome as a drug target for cancer and parasitic infections

[edit]

Given the essential functions of the COP9 signalosome, the complex has been explored as a target for drug discovery. Preclinical studies showed that inhibiting COP9 resulted in death of cancer cells and medically important parasite.[6][7]

References

[edit]
  1. ^ a b Lingaraju, GM; Bunker, RD; Cavadini, S; Hess, D; Hassiepen, U; Renatus, M; Fischer, ES; Thomä, NH (14 August 2014). "Crystal structure of the human COP9 signalosome". Nature. 512 (7513): 161–5. Bibcode:2014Natur.512..161L. doi:10.1038/nature13566. PMID 25043011. S2CID 205239748.
  • ^ Wei, Ning; Chamovitz, Daniel A.; Deng, Xing-Wang (1994). "Arabidopsis COP9 is a component of a novel signaling complex mediating light control of development". Cell. 78 (1): 117–124. doi:10.1016/0092-8674(94)90578-9. ISSN 0092-8674. PMID 8033203. S2CID 205021135.
  • ^ Chamovitz, Daniel A; Wei, Ning; Osterlund, Mark T; von Arnim, Albrecht G; Staub, Jeffrey M; Matsui, Minami; Deng, Xing-Wang (1996). "The COP9 Complex, a Novel Multisubunit Nuclear Regulator Involved in Light Control of a Plant Developmental Switch". Cell. 86 (1): 115–121. doi:10.1016/S0092-8674(00)80082-3. ISSN 0092-8674. PMID 8689678.
  • ^ Seeger, M (1 April 1998). "A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits". The FASEB Journal. 12 (6): 469–478. doi:10.1096/fasebj.12.6.469. PMID 9535219. S2CID 25424324.
  • ^ Wei, N; Serino, G; Deng, XW (December 2008). "The COP9 signalosome: more than a protease". Trends in Biochemical Sciences. 33 (12): 592–600. doi:10.1016/j.tibs.2008.09.004. PMID 18926707.
  • ^ Ghosh, S; Farr, L; Singh, A; Leaton, LA; Padalia, J; Shirley, DA; Sullivan, D; Moonah, S (22 September 2020). "COP9 signalosome is an essential and druggable parasite target that regulates protein degradation". PLOS Pathogens. 16 (9): e1008952. doi:10.1371/journal.ppat.1008952. PMC 7531848. PMID 32960936.
  • ^ Schlierf, A; Altmann, E; Quancard, J; Jefferson, AB; Assenberg, R; Renatus, M; Jones, M; Hassiepen, U; Schaefer, M; Kiffe, M; Weiss, A; Wiesmann, C; Sedrani, R; Eder, J; Martoglio, B (24 October 2016). "Targeted inhibition of the COP9 signalosome for treatment of cancer". Nature Communications. 7: 13166. Bibcode:2016NatCo...713166S. doi:10.1038/ncomms13166. PMC 5078989. PMID 27774986.
  • Further reading

    [edit]
    Retrieved from "https://en.wikipedia.org/w/index.php?title=COP9_signalosome&oldid=1216371148"

    Categories: 
    Proteases
    Post-translational modification
    EC 3.4
    Hidden category: 
    CS1: long volume value
     



    This page was last edited on 30 March 2024, at 15:59 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki